Perturbations in the surface structure of A22 Iraq foot-and-mouth disease virus accompanying coupled changes in host cell specificity and antigenicity

Structure

Volumn 4, Issue 2, 1996, Pages 135-145

  Curry, Stephen ^a,e   Fry, Elizabeth ^b   Blakemore, Wendy ^a   Abu Ghazaleh, Robin ^a   Jackson, Terry ^a   King, Andrew ^a   Lea, Susan ^b   Newman, John ^a   Rowlands, David ^c   Stuart, David ^b,d  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c WELLCOME RESEARCH LABORATORIES   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Antigenicity; Foot and mouth disease virus; Picornavirus; Specificity; X ray crystallography

Indexed keywords

ANIMALIA; FOOT-AND-MOUTH DISEASE VIRUS; MIRIDAE; PICORNAVIRIDAE; APHTHOVIRUS;

VIRUS ANTIGEN;

APHTHOVIRUS; ARTICLE; CHEMISTRY; CHILD; GENETICS; HUMAN; IMMUNOLOGY; MUTATION; PROTEIN CONFORMATION; VIRUS CAPSID; X RAY DIFFRACTION;

ANTIGENS, VIRAL; APHTHOVIRUS; CAPSID; CHILD; HUMANS; MUTATION; PROTEIN CONFORMATION; X-RAY DIFFRACTION;

EID: 0029643960     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-2126(96)00017-2     Document Type: Article

References (58)

1. Vallée, H. & Carre, H. (1922). Sur la pluralité du virus aphteux. C. r. hebed. Seanc. Acad. Sci., Paris. 174, 1498-1500.
2. Colrnan, P.M. (1992). Structural basis of antigenic variation: Studies of influenza virus neuraminidase. Immunol. Cell. Biol. 70, 209-214.
3. Knossow, M., Daniels, R.S., Douglas, A.R, Skehel, J.J. & Wiley, D.C. (1984). Three-dimensional structure of an antigenic mutant of the influenza virus hemagglutinin. Nature 311, 678-700.
4. Tulip, W.R., et al., & Colman, P.M. (1991). Refined atomic structures of N9 subtype influenza virus neuraminidase and escape mutants. J. Mol. Biol. 221, 487-497.
5. Wiley, D.C. & Skehel, J.J. (1987). The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu, Rev. Biochem. 56, 365-394.
6. Rossmann, M.G., et al., & Vriend G. (1985). Structure of a human common cold virus and functional relationship to other picornaviruses. Nature 317, 145-153.
7. Hogle, J.M., Chow, M. & Filman, D.J. (1985). Three-dimensional structure of poliovirus at 2.9 A resolution. Science 229, 1358-1365.
8. Filman, D.J., Syed, R., Chow, M., Macadam, A.J., Minor, P.D. & Hogle, J.M. (1989). Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus. EMBO J. 8, 1567-1579.
9. Kim, S., et al., & McKinlay, M. (1989). Crystal structure of human rhinovirus serotype 1A (HRV1 A). J Mol. Biol. 210, 91-111.
10. Acharya, R., Fry, E., Stuart, D., Fox, G., Rowlands, D. & Brown, F. (1989). The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature 337, 709-716.
11. Oliveira, M.A., et al., & Rossmann M.G. (1993). The structure of human rhinovirus 16. Structure 1, 51-68.
12. Lea, S., et al., & Mateu, M. G. (1994). The structure and antigenicity of a type C foot-and-mouth disease virus. Structure 2, 123-139.
13. 1 and a laboratory antigenic variant, G67. Structure 3, 571-580.
14. Bolwell, C., et al., & Rowlands, D.J. (1989). Host cell selection of antigenic variants of foot-and-moukh disease virus. J. Gen. Virol. 70, 45-57.
15. Domingo, E., et al., & Mateu, M. (1993). New observations on antigenic diversification of RNA viruses. Antigenic variation is not dependent on immune selection. J. Gen. Virol. 74, 2039-2045.
16. Robertson, J.S., et al., & Schild, G.C. (1987). Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A (H1N1) virus. Virology 160, 31-37.
17. Schild, G.C., Oxford, J.S., de Jong, J.C. & Webster, R.G. (1983). Evidence for host-cell selection of influenza virus antigenic variants. Nature 303, 706-709.
18. Kodihalli, S., Justewicz, D.M., Gubareva, L.V. & Webster, R.G. (1995). Selection of a single amino acid substitution in the hemagglutinin molecule by chicken eggs can render Influenza A virus (H3) candidate vaccine ineffective. J. Virol. 69, 4888-4897.
19. Meyerhans, A., et al., & Wain-Hobson, S. (1989). Temporal fluctuations in HIV quasi species in vivo are not reflected by sequential isolations. Cell 58, 901-910.
20. Diez, J., et al., & Domingo, E. (1990). Unique amino acid substitutions in the capsid proteins of foot-and-mouth disease virus from a persistent infection in cell culture. J. Virol. 64, 5519-5528.
21. Mason, P.W., Rieder, E. & Baxt, B. (1994). RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proc. Natl. Acad. Sci. USA 91, 1932-1936.
22. Yewdell, J.W., Caton, A.J. & Gerhard, W. (1986). Selection of influenza A virus adsorptive mutants by growth in the presence of a mixture of monoclonal antihemagglutinin antibodies. J. Virol. 57, 623-628.
23. Temoltzin-Palacios, F. & Thomas, D.B. (1994). Modulation of immunodominant sites in influenza hemagglutinin compromise antigenic variation and select receptor-binding variant viruses. J. Exp. Med. 179, 1719-1724.
24. Fox, G., Parry, N.R., Barnett, P.V., McGinn, B., Rowlands, D. & Brown, F. (1989). The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J. Gen. Virol. 70, 625-637.
25. Baxt, B. & Becker, Y. (1990). The effect of peptides containing the arginine-glycine-aspartic acid sequence on the adsorption of foot-and-mouth disease virus to tissue culture cells. Virus Genes 4, 73-83.
26. Saiz, J.C., Gonzalez, M.J., Borca, M.V., Sobrino, F. & Moore, D.M. (1991). Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants. J. Virol. 65, 2518-2524.
27. Thomas, A.A.M., Woortmeijer, R.J., Puijk, W. & Barteling, S.J. (1988). Antigenic sites on foot-and-mouth disease virus type A10. J. Virol. 62, 2782-2789.
28. Kitson, J.D.A., McCahon, D. & Belsham, G.J. (1990). Sequence analysis of monoclonal antibody resistant mutants of type O foot and mouth disease virus: evidence for the involvement of three surface exposed capsid proteins in four antigenic sites. Virology 179, 26-34.
29. Baxt, B., Vakharia, V., Moore, D.M., Franke, A.J. & Morgan, D.O. (1989). Analysis of neutralizing antigenic sites in the surface of type A12 foot-and-mouth disease virus. J. Virol. 63, 2143-2151.
30. Rweyemamu, M.M., Ouldridge, E.J., Head, M. & Purse, F. (1984). Evaluation of the antigenic variation within type A foot and mouth disease virus isolates from Asia. J. Biol. Stand. 12, 191-194.
31. Bolwell, C., Parry, N.R. & Rowlands, D.J. (1992). Comparison between in vitro neutralization titres and in vivo protection against homologous and heterologous challenge induced by vaccines prepared from two serologically distinct variants of foot-and-mouth disease virus, serotype A22. J. Gen. Virol. 73, 727-731.
32. Palmenberg, A.C. (1989). Sequence alignments of picornaviral capsid proteins, In Molecular Aspects of Picornavirus Infection and Detection, (Semler, B.L. & Ehrenfeld, E., eds), pp. 211-241, American Society for Microbiology, Washington.
33. Logan, D., et al., & Fry, E. (1993). Structure of a major immunogenic site on foot-and-mouth disease virus. Nature 362, 566-568.
34. Bittle, J.L., et al., & Brown, F. (1982). Protection against foot-and-mouth disease virus by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298, 30-33.
35. DiMarchi, R., Brooke, G., Gale, C., Cracknell, V., Doel, T. & Mowat, N. (1986). Protection of cattle against foot-and-mouth disease virus by a synthetic peptide. Science 232, 639-641.
36. Stromaier, K., Franze, R. & Adamm, K.-H. (1982). Location and characterization of the antigenic portion of the FMDV immunising protein. J. Gen. Virol. 59, 295-306.
37. Verdagauer, N., Mateu, M.G., Andreu, D., Giralt, E., Domingo, E. & Fita, I. (1995). Structure of the major antigenic loop of foot-and-mouth disease virus complexed with a neutralizing antibody: direct involvement of the Arg-Gly-Asp motif in the interaction. EMBO J. 14, 1690-1696.
38. Parry, N. R., et al., & Stuart, D. (1990). Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. Nature 347, 569-572.
39. Bolwell, C., Clarke, B.E., Parry, N.R., Ouldridge, E., Brown, F. & Rowlands, DJ. (1989). Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies. J. Gen. Virol. 70, 59-68.
40. Hwang, S.S., Boyle, T.J., Lyerly, H.K. & Cullen, B.R. (1991). Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253, 71-74.
41. Milich, L., Margolin, B. & Swanstrom, R. (1993). V3 Loop of the Human immunodeficiency virus type 1 Env protein: interpreting sequence variability. J. Virol. 67, 5623-5634.
42. Shioda, T., et al., & Nagai, Y. (1994). A naturally occurring single basic amino acid substitution in the V3 region of the human immunodeficiency virus type 1 Env protein alters the cellular host range and antigenic structure of the virus. J. Virol. 68, 7689-7696.
43. Hattori, T., Koito, A., Takatsuki, K., Kido, H. & Katunuma, N. (1989). Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection; FEBS Lett. 248, 48-52.
44. + lymphocytes immunologically reactive with antibody inhibiting syncytia induced by HIV-1. J. Biol. Chem. 265, 21979-21985.
45. Stephens, P.E., Clements, G. & Yarranton, G.T. (1990). A chink in HIV's armour? Nature 343, 219.
46. Javaherian, K., et al., & Matthews, T.J. (1989). Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc. Natl. Acad. Sci. USA 86, 6768-6772.
47. Palker, T.J., et al., & Haynes, B.F. (1988). Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc. Natl. Acad. Sci. USA 85, 1932-1936,
48. Pfaff, E., Mussgay, M., Bohrn, H.O., Schulz, G.E. & Schaller, H. (1962). Antibodies against a preselected peptide recognize and neutralise foot-and-mouth disease virus. EMBO J. 1, 869-874.
49. Rieder, E., Baxt, B. & Mason, P.W. (1994). Animal-derived antigenic variants of foot-and-mouth disease virus type A12 have low affinity for cells in culture. J. Virol. 68, 5296-5299.
50. Curry, S., et al., & Stuart, D. (1992). Crystallization and preliminary X-ray analysis of three serotypes of foot-and-mouth disease virus. J. Mol. Biol. 228, 1263-1268.
51. Harlos, K. (1992). Microbridges for sitting drop crystallizations. J. Appl. Cryst 25, 536-538.
52. Stura, E.A. & Wilson, I.A. (1990). Analytical and production seeding techniques. Methods 1, 38-49.
53. Fry, E., Acharya, R. & Stuart, D. (1993). Methods used in the structure determination of foot-and-mouth disease virus. Acta Cryst. A 49, 45-55.
54. Collaborative Computational Project, Number 4. (1994). The CCP4 Suite: programs for protein crystallography. Acta Cryst. D 50, 760-763.
55. Brünger, AT. (1992). X-PLOR Version 3.0. Yale University, Newhaven, CT.
56. Jones, T.A. (1978). Interactive computer graphics: FRODO. Methods Enzymol. 115, 157-171.
57. Engh, R.A. & Huber, R. (1991). Accurate bond and angle parameters for X-ray protein-structure refinement. Acta Cryst. A 47, 392-400.
58. Jones, T.A., Zou, J.Y., Cowan, S.W. & Kjeldgaard, M, (1991). Improved methods for building protein models in electron density maps and the location of errors in these maps. Acta Cryst. A 47, 110-119.